SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MGV who wrote (1179)6/12/1999 1:40:00 PM
From: Feathered Propeller  Read Replies (2) of 1754
 
VISX shines

Laser vision correction company VISX (VISX) soared 18-7/16 to 78-15/16, flying on the magic carpet of positive remarks from two investment firms and its own first-quarter profit prospects.
In an overnight statement, the company said earnings will beat Wall Street estimates by as much as 50 percent, spurring Bank Boston Robertson Stephens to rate the stock a "buy," while Warburg upped its 1999 price target to $110 from $76.

cnnfn.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News